SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000849146-22-000059
Filing Date
2022-08-23
Accepted
2022-08-23 16:07:00
Documents
14
Period of Report
2022-08-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lfvn-20220823.htm   iXBRL 8-K 37539
2 EX-99.1 lfvnq42022earningsrelease.htm EX-99.1 278045
6 logoa23.jpg GRAPHIC 6462
  Complete submission text file 0000849146-22-000059.txt   486994

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfvn-20220823.xsd EX-101.SCH 1924
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfvn-20220823_lab.xml EX-101.LAB 25154
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfvn-20220823_pre.xml EX-101.PRE 13064
8 EXTRACTED XBRL INSTANCE DOCUMENT lfvn-20220823_htm.xml XML 12156
Mailing Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043
Business Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043 801-432-9000
Lifevantage Corp (Filer) CIK: 0000849146 (see all company filings)

IRS No.: 841097796 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35647 | Film No.: 221187534
SIC: 2834 Pharmaceutical Preparations